Rarity Bioscience

Uppsala, Sweden

Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.

$536K raised

Feb 2023

Seed

Biotechnology Health Care Medical

Top Investors

Novalis Biotechnology Incubation Navigare Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rarity Bioscience

How much funding has Rarity Bioscience raised?

Rarity Bioscience has raised $536K in total funding. The most recent round was Seed. The last funding was announced in February 2023.

Who are Rarity Bioscience's investors?

Rarity Bioscience's investors include Novalis Biotechnology Incubation, Navigare Ventures.

Where is Rarity Bioscience headquartered?

Rarity Bioscience is headquartered in Uppsala, Sweden.

What does Rarity Bioscience do?

Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.

What stage is Rarity Bioscience at?

Rarity Bioscience is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 6, 2023.

MLA

"Rarity Bioscience — Funding & Investors." VCBacked, February 6, 2023, https://www.vcbacked.co/company/rarity-bioscience. Accessed July 2, 2026.

APA

VCBacked. (2023). Rarity Bioscience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rarity-bioscience

Wikipedia (cite web)

{{cite web |title=Rarity Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/rarity-bioscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 6, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K